BioAscent will be attending the 9th Fragment-based Drug Discovery Meeting on 3-5 March 2024, at Hinxton Hall, Wellcome Genome Campus, Cambridge.

The aim of the 9th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in fragment-based drug discovery that have delivered compounds to late-stage medicinal chemistry, preclinical or clinical programmes. The conference brings together chemists, biophysicists, structural biologists and industry professionals to learn more about this approach to drug discovery.

We are pleased to be exhibiting at the 9th Fragment-based Drug Discovery Meeting at booth 8. If you would like to arrange a meeting, please get in touch by emailing info@bioascent.com.

To find out more about the event and to register, click here.